Nathan Dowden
President chez ENTRADA THERAPEUTICS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Nathan J.
Dowden is currently the President & Chief Operating Officer at Entrada Therapeutics, Inc. He previously worked as a Managing Director at Huron Consulting Group, Inc. from 2014 to 2016.
He also held the position of Managing Director at Frankel Group LLC.
Prior to that, he worked as a Senior Consultant at Ernst & Young LLP and as a Principal at G.D.
Searle & Co., Inc. From 2013 to 2019, he worked as an Analyst at CIGNA HealthCare, Inc. He also served as the Senior VP-Strategy & Corporate Development at Rubius Therapeutics, Inc. from 2016 to 2019.
Mr. Dowden completed his undergraduate degree at the University of Connecticut and holds an MBA from The University of Chicago Booth School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ENTRADA THERAPEUTICS INC
0,41% | 06/03/2024 | 137 204 ( 0,41% ) | 2 M $ | 31/03/2024 |
Postes actifs de Nathan Dowden
| Sociétés | Poste | Début |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | President | 01/01/2024 |
Anciens postes connus de Nathan Dowden
| Sociétés | Poste | Fin |
|---|---|---|
| RUBIUS THERAPEUTICS | Corporate Officer/Principal | 25/07/2019 |
CIGNA HealthCare, Inc.
 CIGNA HealthCare, Inc. Managed Health CareHealth Services CIGNA HealthCare, Inc. provides medical benefit plans, dental coverage, behavioral health coverage, pharmacy benefits, and products and services. the company is headquartered in Bloomfield, CT. | Corporate Officer/Principal | 01/01/2019 |
| HURON CONSULTING GROUP INC. | Corporate Officer/Principal | 01/03/2016 |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Corporate Officer/Principal | - |
Formation de Nathan Dowden
| University of Connecticut | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HURON CONSULTING GROUP INC. | Commercial Services |
| Entreprise privées | 5 |
|---|---|
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
CIGNA HealthCare, Inc.
CIGNA HealthCare, Inc. Managed Health CareHealth Services CIGNA HealthCare, Inc. provides medical benefit plans, dental coverage, behavioral health coverage, pharmacy benefits, and products and services. the company is headquartered in Bloomfield, CT. | Health Services |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
| Entrada Therapeutics, Inc. |
